A new generation Mpro inhibitor with potent activity against SARS-CoV-2 Omicron variants
Chong Huang(Sichuan University), Shengyong Yang(Sichuan University), Chaemin Yoon(University of Hong Kong), Bingjie Hu(Wenzhou Medical University), Yueyue Li(Sichuan University), Xiu Fen Zhao(Sichuan University), Huiping Shuai(Chinese University of Hong Kong), Hin Chu(HKU-Pasteur Research Pole), Ronggang Ma(Sichuan University), Lingwan Xie(Sichuan University), Anjie Xia(Sichuan University), Jinshan Nan(Sichuan University), Yuxin Hou(University of Hong Kong), Jian Lei(Sichuan University), Falu Wang(Sichuan University), Nihong Guo(Sichuan University), Yifei Wang(Southwest Medical University), Shiyu Zhang(Sichuan University), Shanshan Zhang(Shandong Normal University), Jiahao Zhang(Sichuan University), Rui Zeng(Sichuan University), Qiao Huang(Sichuan University), Jing You(Sichuan University), Jingxin Qiao(Sichuan University), Ruicheng Yang(Sichuan University), Baoxue Quan(Sichuan University), Zhen Fang(Shanghai Customs College), Haixing Xu(Sichuan University)
Cited by 82
Related Papers
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
|The Lancet|2020|9.6k
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
|Emerging Microbes & Infections|2020|3.3k
Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
|Signal Transduction and Targeted Therapy|2021|1.6k